Private financing brings in $82.8mm for Keryx
Executive Summary
Keryx Biopharmaceuticals (developing therapeutics for cancer, diabetes, and renal disease) has raised $82.8mm from a private placement of 4.5mm common shares at $18.40 each (about market average) to two institutional investors.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice